medigraphic.com
Instituto Nacional de Neurología y Neurocirugía

2009, Número 1

<< Anterior Siguiente >>

Arch Neurocien 2009; 14 (1)


Enfermedad de Moyamoya

Farias SF, Ishikawa T, Yoshida Y, Moroi J, Sawada M, KN, Mutoh T, Jun R, Farias SCV

Idioma: Ingles.
Referencias bibliográficas: 83
Paginas: 33-39
Archivo PDF: 78.25 Kb.


RESUMEN

La enfermedad de Moyamoya es una hipoplásia bilateral de las arterias carótidas muy frecuente en Japón y rara en caucásicos con predominancia en mujeres, puede producir isquemia cerebral con ataques isquémicos y/o hemorragia y producir movimientos involuntarios o convulsiones. Su etiología no es conocida. El tratamiento es la cirugía con comunicación de la arteria temporal a la cerebral media o aplicación de un injerto múscular en la corteza cerebral con lo que los ataques isquémicos desaparecen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Takeuchi K, Shimizu K. Hypoplasia of the bilateral internal carotid arteries. No To Shinkei 1957; 9: 37-43.

  2. Kudo T. Spontaneous occlusion of the circle of Willis: A disease apparently confined to Japanese. Neurology 1968; 18: 485- 96.

  3. Suzuki J, Takaku A. Cerebrovascular ‘Moyamoya disease’: Adisease showing abnormal net-like vessels in base of brain. Arch Neurol 1969; 20: 288-99.

  4. Fukui M, Kawano T. Follow up study of registered cases in 1995. In: Fukui M (ed). Annual report 1995 of the researchCommittee on Spontaneous Occlusion of the Circle of Willis (Moyamoya disease). Tokyo: Ministry of Health and Welfare, Japan, 1996: 12-6.

  5. Aoyagi M, Ogami K, Matsushima Y, Shikata M, Yamamoto M, Yamamoto K. Human leukocyte antigen in patients with moyamoya disease. Stroke 1995; 26: 415-7.

  6. Ikeda H, Sasaki T, Yoshimoto T, Fukui M, Arinami T. Mapping ofa familial moyamoya disease gene to chromosome 3p24.2- p26. Am J Hum Genet 1999; 64: 533-7.

  7. Vila-Herrero E, Padilla-Parrado F, Vega-Pérez J, García-Casares N, Heras-Pérez J, Romero-Acebal M. Síndrome de moyamoya y displasia arterial asociados a síndrome de Down. Rev Neurol 2004; 34: 943-5.

  8. Leno C, Mateo I, Cid C, Berciano J, Sedano C. Autoimmunity in Down’s syndrome: another possible mechanism of moyamoya disease. Stroke 1998; 29: 868-9.

  9. Fukui M. Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis (‘moyamoya’ disease). Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan. Clin Neurol Neurosurg 1997; 99 (Suppl 2): S238-40.

  10. Horn P, Pfister S, Bueltmann E, Vajkoczy P, Schmiedek P. Moyamoya like vasculopathy (moyamoya syndrome) in children. Childs Nerv Syst 2004; 20: 382-91.

  11. Handa H, Yonekawa Y, Goto Y. Analysis of the filing data bank of 1500 cases of spontaneous occlusion of the circle of Willis and follow-up study of 200 cases for more than 5 years. In: Handa H (ed.). Annual Report (1984) of Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya disease). Tokyo: Ministry of Health and Welfare, Japan, 1985; 14-22.

  12. Oka K, Yamashita M, Sadoshima S, Tanaka K. Cerebral hemorrhage in Moyamoya disease at autopsy. Virchow Arch (A) 1981; 392: 247-61.

  13. Cramer SC, Robertson RL, Dooling EC, Scout RM. Moyamoya and Down syndrome. Clinical and radiological features. Stroke 1996; 27:2131-5.

  14. Kitahara T, Ariga N, Yamaura A, Makino H, Maki Y. Familial occurrence of moya-moya disease: report of three Japanese families. J Neurol Neurosurg Psychiatry 1979; 42:208-14.

  15. Aylett SE, Britton JA, De Sousa CMCP. Down syndrome and moyamoya disease: presentation with subarachnoid hemorrhage. Pediatr Neurol 1996; 14:259-61.

  16. Takeda K, Takahashi S, Higano S, Kurihara N, Haginoya K, Shirane R, et al. Cortical laminar necrosis in a patient with moyamoya disease associated with Down syndrome. Radiat Med 1997; 15: 59-63.

  17. Takanashi J, Sugita K, Honda A, Niimi H. Moyamoya syndrome in a patient with Down syndrome presenting with chorea. Pediatr Neurol 1993; 9:396-8.

  18. Ogawa A, Nakamura N, Yoshimoto T. Cerebral blood flow in Moyamoya disease. Part 2: autoregulation and CO2 response. Acta Neurochir (Wien) 1990; 105: 30-4.

  19. Fukui M. Guideline for the diagnosis of spontaneous occlusionof the circle of Willis. In: Fukui M (ed.). Annual Report (1994) of Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya disease). Tokyo: Ministry of Health and Welfare, Japan, 1995.

  20. Kodama N, Aoki Y, Hiraga H, Wada T, Suzuki J. Electroencephalographic findings in children with moyamoya disease. Arch Neurol 1979;36:16-9.

  21. Abe H, Kazumata K, Kuroda S, Houkin K. Regional cerebral hemodynamics during rebuild up phenomenon in childhood moyamoya disease-analysis by using gg»Tc-HMPAO SPECT. Annual report of 1993 of the Research Committee on Spontaneous occlusion of the circle of Willis (moyamoya disease) of the Ministry of Health and Welfare, Japan, 88-94.

  22. lkezaki K, Matsushima T, Kuwabara Y, Suzuki SO, Nomura T, Fukui M. Cerebral circulation and oxygen metabolism in childhood moyamoya disease: a perioperative positron emmision tomography study. J Neuorsurg 1994;81:843-50.

  23. Taki W, Yonekawa Y, Kobayashi A. Cerebral circulation and oxygen metabolism in moyamoya disease of ischemic type in children. Child Nerv Syst 1988; 4:259-62.

  24. Evaluation of Neuronal Loss in Adult Moyamoya Disease by 123I-Iomazenil SPECT. Shinya Sato, Reizo Shirane, Shin Maruoka, and Takashi Yoshimoto. Surg Neurol 1999;51:158-63.

  25. Hanakita J, Kondo A, Ishikawa J. An autopsy case of moyamoya disease. No Shinkei Geka 1982; 10: 531-9.

  26. Hosoda Y. A pathomorphological analysis of so-called ‘spontaneous occlusion of the circle of Willis´ (Cerebrovascular moyamoya disease). No To Shinkei 1974; 26: 471-81.

  27. Hosoda Y. Pathology of so-called ‘spontaneous occlusion of the circle of Willis´. Pathol Annu 1984; 19: 221-4.

  28. Handa H, Tani K, Kajiwara H. Autopsy case of so-called arterialrete in an adult. No To Shinkei 1969; 21: 181-91.

  29. Yamashita M, Oka K, Tanaka K. Histopathology of the brain vascular networks in moyamoya disease. Stroke 1983;14:50-8.

  30. Yamashita M, Oka K, Tanaka K. Cervico-cephalic arterial thrombi and thromboemboli in moyamoya disease, possible correlation with progressive intimal thickening in the intracranial major arteries. Stroke 1984; 15: 264-70.

  31. Ikeda E, Hosoda Y. Distribution of thrombotic lesions in the cerebral arteries in spontaneous occlusion of the circle of Willis: Cerebrovascular moyamoya disease. Clin Neuropathol 1993; 12: 44-8.

  32. Hosoda Y, Ikeda E, Hirose S. Histopathological studies on spontaneous occlusion in the circle of Willis (Cerebrovascular moyamoya disease). Clin Neurol Neurosurg 1997;(S.2):203-8.

  33. Masashi Fukui, Shinji Kono, Katsuo Sueishi and Kiyonobu Ikezaki. Moyamoya disease. Neuropathology 2000; 20, 61-4.

  34. Fukui M. Current state of study on moyamoya disease in Japan. Surg Neurol 1997; 47: 138-43.

  35. Takahashi A, Yukata S, Koyohiro H. The cerebrospinal fluid in patients with moyamoya disease contains high level of basic fibroblast growth factor. Neuroscience Letter 1993;160:214-6.

  36. Suzuki H, Hoshimaru M, Takahashi JA. Immunohistochemical reactions for fibroblast growth factor in arteries of patients with moyamoya disease. Neurosurgery 1994; 35: 20-5.

  37. Ikeda H, Sasaki T, Yoshimoto T. Mapping of familial moyamoya disease gene to chromosome 3p24.2-p26. Am J Hum Genet 1999; 64: 533-7.

  38. Inoue TK, Ikezaki K, Sasazuki T. DNA typing of HLA in patients with moyamoya disease. Jpn H Human Genet 1997;42: 507-15.

  39. Inoue TK, Ikezaki K, Sasazuki K. Linkage analysis of moyamoya disease on chromosome 6. J Child Neurol 2000; 15: 179-82.

  40. Yamauchi T, Tada M, Houkin K. Linkage of familial moyamoya disease (spontaneous occlusion of the circle of Willis) to chromosome 17q25. Stroke 2000; 31: 930-5.

  41. Andeejani AM, Salih MA, Kolawole T, Gader AM, Malabarey TO, al Damegh S. Moyamoya disease with unusual angiographic findings and protein C deficiency: review of the literature. J Neurol Sci 1998; 159: 11-6.

  42. Akgun D, Yilmaz S, Senbil N, Aslan B, Gurer YY. Moyamoya syndrome with protein S deficiency. Eur J Pediatr Neurol 2000; 4: 185-8.

  43. Nishizawa S, Ryu H, Yokoyama T. Post-irradiation vasculopathy of intracranial major arteries in children-report of two cases. Neurol Med Chir (Tokyo) 1991;31:336-41.

  44. Rajakulasingam K, Cerullo LJ, Raimondi AJ. Childhood moyamoya syndrome. Postradiation pathogenesis. Childs Brain 1979;5:467-75.

  45. Okuno T, Prensky AL, Gado M. The Moyamoya syndrome associated with irradiation of an optic glioma in children: report of two cases and review of the literature. Pediatr Neurol 1985;1:311-6.

  46. Bitzer M, Topka H. Progressive cerebral occlusive disease after radiation therapy. Stroke 1995; 26:131-6.

  47. Kestle JR, Hoffman HJ, Mock AR. Moyamoya phenomenon after radiation for optic glioma. J Neurosurg 1993; 79: 32-5.

  48. Brant-Zawadzki M, Anderson M, De Armond SJ. Radiationinduced large intracranial vessel occlusive vasculopathy. AJR Am J Roentgenol 1980;134:51-5.

  49. Rudoltz MS, Regine WF, Langston JW. Multiple causes of Cerebrovascular events in children with tumors of the parasellar region. J Neurooncol 1998;37:251–261.

  50. Mori K, Takeuchi J, Ishikawa M, et al. Occlusive arteriopathy and brain tumor. J Neurosurg 1978;49: 22–35.

  51. Amro A, Schultz H. Moyamoya vasculopathy after cranial irradiation-a case report. Acta Oncol 1995;34: 261-3.

  52. Hirata Y, Matsukado Y, Mihara Y, et al. Occlusion of the internal carotid artery after radiation therapy for the chiasmal lesion. Acta Neurochir (Wien) 1985;74:141–7.

  53. Kitano S, Sakamoto H, Fujitani K, Kobayashi Y. Moyamoya disease associated with a brain stem glioma. Childs Nerv Syst 2000;16:251-5.

  54. Hug EB, Muenter MW, Archambeau JO. Conformal proton radiation therapy for pediatric low-grade astrocytomas. Strahlenther Onkol 2002;178:10-17.

  55. Kondoh T, Morishita A, Kamei M. Moyamoya syndrome after prophylactic cranial irradiation for acute lymphocytic leukemia. Pediatr Neurosurg 2003;39:264-9.

  56. Serdaroglu A, Simsek F, Gucuyener K. Moyamoya syndrome after radiation therapy for optic pathway glioma: case report. J Child Neurol 2000;15:765-7.

  57. Sinsawaiwong S, Phanthumchinda K. Progressive cerebral occlusive disease after hypothalamic astrocytoma radiation therapy. J Med Assoc Thai 1997;80:338-42.

  58. Yamamoto T, Koeda T. [Moyamoya-like vascular changes 6 years after radiation therapy in a boy]. No To Hattatsu 1996;28:525-7.

  59. Darmody WR, Thomas LM, Gurdjian ES. Postirradiation vascular insufficiency syndrome. Case report. Neurology 1967;17:1190-2.

  60. Taveras JM. Multiple progressive intracranial arterial occlusions: a syndrome of children and young adults. AJR Am J Roentgenol 1969; 106:235-68.

  61. Hilal SK, Solomon GE, Gold AP, Carter S. Primary cerebral arterial occlusive disease in children. II. Neurocutaneous syndromes. Radiology 1971;99:87–94.

  62. Debrun G, Lacour P. A new case of moyamoya disease associated with several intracavernous aneurysms. Neuroradiology 1974;7: 277-82.

  63. Painter MJ, Chutorian AM, Hilal SK. Cerebrovasculopathy following irradiation in childhood. Neurology 1975; 25: 189-94.

  64. Montanera W, Marotta TR, terBrugge KG. Cerebral arteriovenous malformations associated with moyamoya phenomenon. AJNR Am J Neuroradiol 1990; 11: 1153-6.

  65. Ono K, Fujimoto T, Komatsu K. [Case of occlusion of the circle of Willis associated with the growth of abnormal vascular networks at the base of the brain; its relation to the pathogenesis of so-called “moyamoya” disease]. No To Shinkei 1977;29:37-43.

  66. Kyoi K, Kirino Y, Sakaki T. Therapeutic irradiation of brain tumor and cerebrovasculopathy. No Shinkei Geka 1989; 17:163-70.

  67. Beyer RA, Paden P, Sobel DF, Flynn FG. Moyamoya pattern of vascular occlusion after radiotherapy for glioma of the optic chiasm. Neurology 1986;36:1173-8.

  68. Mitchell WG, Fishman LS, Miller JH. Stroke as a late sequela of cranial irradiation for childhood brain tumors. J Child Neurol 1991;6: 128-33.

  69. Fajardo LF, Berthrong M. Vascular lesions following radiation. Pathol Annu 1988;23:297–330.

  70. Omura M, Aida N, Sekido K. Large intracranial vessel occlusive vasculopathy after radiation therapy in children: clinical features and usefulness of magnetic resonance imaging. Int J Radiat Oncol Biol Phys 1997; 38: 241-9.

  71. NJ Ullrich, R. Robertson, DD Kinnamon, RM Scott, MW Kieran, CD Turner, SN Chi, et al. Moyamoya following cranial irradiation for primary brain tumors in children. Neurology 2007;68:932-8.

  72. Ken-ichiro Kikuta, Yasushi Takagi, Kazuhiko Nozaki et al. Effects of intravenous anesthesia with propofol on regional cortical blood flow and intracranial pressure in surgery for moyamoya disease. Surgical Neurology 2007; 68:421-4.

  73. Iwama T, Hashimoto N, Yonekawa Y. The relevance of hemodynamic factors to perioperative ischemic complications in childhood moyamoya disease. Neurosurgery 1996;38:1120-6.

  74. Sakamoto T, Kawaguchi M, Kurehara K, Kitaguchi K, Furuya H, Karasawa J. Risk factors for neurologic deterioration after revascularization surgery in patients with moyamoya disease. Anesth Analg 1997;85:1060-5.

  75. Sato K, Shirane R, Yoshimoto T. Perioperative factors related to the development of ischemic complications in patients with moyamoya disease. Child’s Nerv Syst 1997;13:68-72.

  76. Abouleish E, Wiggins M, Ali V. Combined spinal and epidural anesthesia for cesarean section in a parturient with moyamoya disease. Acta Anaesthesiol Scand 1998; 42:1120-3.

  77. Furuya A, Matsukawa T, Ozaki M, Kumazawa T. Propofol anesthesia for cesarean section successfully managed in a patient with moyamoya disease. J Clin Anesth 1998;10:242-5.

  78. Kansha M, Irita K, Takahashi S, Matsushima T. Anesthetic management of children with moyamoya disease. Clin Neurol Neurosurg 1997;99(Suppl 2):S110-3.

  79. Kurehara K, Ohnishi H, Touho H, Furuya H, Okuda T. Cortical blood flow response to hypercapnia during anaesthesia in moyamoya disease. Can J Anaesth 1993; 40:709-13.

  80. Miyamoto S, Nagata I, Hashimoto N, Kikuchi H. Direct anastomotic bypass for cerebrovascular moyamoya disease. Neurol Med Chir (Tokyo) 1998;8 (Suppl):294-6.

  81. Matta BF, Heath KJ, Tipping K, Summors AC. Direct cerebral vasodilatory effects of sevoflurane and isoflurane. Anesthesiology 1999 ; 91:677- 80.

  82. AM Hogan, FJ Kirkham, EB Isaacs, AM Wade et al. Intellectual decline in children with moyamoya and sickle cell anaemia. Developmental Medicine & Child Neurology 2005, 47: 824-9.

  83. Shinya Sato, Reizo Shirane, Shin Maruoka et al. Evaluation of Neuronal Loss in Adult Moyamoya Disease by 123I-Iomazenil SPECT. Surg Neurol 1999; 51:158–63.




2020     |     www.medigraphic.com